Cynosure. Announces 2.6M Share Offering

Cynosure, Inc. CYNO (the "Company"), a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced that it has commenced an underwritten registered public offering of 2,600,000 shares of its class A common stock. In addition, El.En. S.p.A. is offering 600,000 shares of the Company's class A common stock. Leerink Swann LLC, the underwriter for this offering, has the option for a period of up to 30 days from the date of the prospectus supplement to purchase up to an additional 240,000 shares from the Company and up to an additional 240,000 shares from El.En. S.p.A. at the public offering price less underwriting discounts and commissions.  The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the final size or terms of the offering. The Company intends to use the net proceeds from the shares sold by it in this offering for general corporate purposes and to fund its potential acquisition of complementary products, technologies or businesses. The Company will not receive any proceeds from the sale of the shares by El.En. S.p.A. The shares See full press release